Home › Glioblastoma › Texas

Pag-aaral pangklinika para sa Glioblastoma sa Texas

33 pag-aaral para sa Glioblastoma ang naghahanap ng mga kalahok sa mga site sa Texas.

Mga Lungsod sa Texas

Opisyal na teksto ng pag-aaral (English)

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

University of Texas - MD Anderson Cancer Center, Houston

Nagre-recruitPhase 2/3

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT03970447

GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma

Baylor St. Luke's Medical Center, Houston

Nagre-recruitPhase 1

Edad 21 hanggang 70 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06815432

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

University of Texas Southwestern Medical Center, Dallas

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT05902169

A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM

MD Anderson Cancer Center, Houston

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05303467

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

The University of Texas Southwestern Medical Center - Harold C Simmons Comprehensive Cancer Center, Dallas
Baylor College of Medicine, Houston

Nagre-recruitPhase 1/2

Hanggang edad 25 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT04094610

MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma

M D Anderson Cancer Center, Houston

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT03896568

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Baylor, Scott and White Research Institute, Dallas

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06047379

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

Baylor Scott & White Research Institute, Dallas
The University of Texas MD Anderson Cancer Center, Houston
South Texas Accelerated Research Therapeutics (START), San Antonio

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT05765812

Anti-GD2 ADC M3554 in Advanced Solid Tumors

The University of Texas MD Anderson Cancer Center, Houston

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06641908

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

NEXT Dallas - Oncology Department, Irving
START | San Antonio, San Antonio

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06914128

Targeted Pediatric High-Grade Glioma Therapy

Texas Children's Hospital, Houston

Nagre-recruitObservasyonal na pag-aaral

12 Months – 39 Years · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05839379

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

MD Anderson Cancer Center, Houston

Nagre-recruitPhase 1

36 Months – 22 Years · Lahat ng kasarian · Na-update Set 4, 2026 · NCT03911388

Study of Olutasidenib and Temozolomide in HGG

Texas Children's Hospital, Houston

Nagre-recruitPhase 2

Edad 12 hanggang 39 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

University of Texas Southwestern Medical Center, Dallas
MD Anderson Cancer Center, Houston
University of Texas Health Mays Cancer Center, San Antonio

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT05303519

A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent Glioblastoma

MD Anderson Cancer Center, Houston

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT07579208

Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)

Excel Diagnostics & Nuclear Oncology Center, Houston

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT07733674

A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma

The University of Texas M. D. Anderson Cancer Center, Houston
The University of Texas MD Anderson Cancer Center, Houston

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 21, 2026 · NCT06672575

Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors

M D Anderson Cancer Center, Houston

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 20, 2026 · NCT04479696

Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas

M D Anderson Cancer Center, Houston

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 16, 2026 · NCT04623931

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

UTHealth Houston, Houston
Baylor College of Medicine, Houston
The University of Texas Health Science Center at San Antonio, San Antonio

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 1, 2026 · NCT06805305

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

Texas Children's Hospital, Houston

Nagre-recruitMaagang Phase 1Malugod na tinatanggap ang malusog na boluntaryo

Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT06333899

Imaging Acetadote Metabolism in Glioblastoma

University of Texas Southwestern Medical Center, Dallas

Nagre-recruitMaagang Phase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT07387666

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Texas Children's Hospital, Houston

Nagre-recruitPhase 2

12 Months – 39 Years · Lahat ng kasarian · Na-update May 29, 2026 · NCT05843253

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

MD Anderson Cancer Center, Houston

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT06810544

HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM

Houston Methodist Neurological Institute, Houston

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 30, 2026 · NCT03596086

Sacituzumab Govitecan in Recurrent Glioblastoma

Texas Oncology Austin, Austin
University of Texas Health Science Center San Antonio at the Cancer Therapy and Research Center, San Antonio

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 30, 2026 · NCT04559230

HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM

Houston Methodist Neurological Institute, Houston

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 30, 2026 · NCT03603405

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Dallas
Massive Bio SYNERGY-AI site, Houston
Massive Bio SYNERGY-AI site, Temple

Nagre-recruitObservasyonal na pag-aaral

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Mary Crowley Cancer Research, Dallas
University of Texas Southwestern Medical Center, Dallas
MD Anderson Cancer Center, Houston

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2025 · NCT05941507

Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma

Mays Cancer Center, UT Health San Antonio, San Antonio

Nagre-recruitPhase 2

Lahat ng edad · Lahat ng kasarian · Na-update Ago 27, 2025 · NCT04863950

Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma

UT MD Anderson Cancer Center, Houston

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 25, 2025 · NCT05879367

Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment

The Cancer Therapy and Research Center at UTHSCSA, San Antonio

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 30, 2025 · NCT05460507

Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

UT Southwestern Medical Center, Dallas
The Cancer Therapy and Research Center at UTHSCSA, San Antonio

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 26, 2025 · NCT01906385

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.